Santhera Pharmaceuticals Holding AG (SWX: SANN)
Switzerland
· Delayed Price · Currency is CHF 8.30
+0.27 (3.36%)
Nov 19, 2024, 5:30 PM CET
SANN Revenue
Santhera Pharmaceuticals Holding AG had revenue of 14.11M CHF in the half year ending June 30, 2024, with 125.82% growth. This brings the company's revenue in the last twelve months to 113.59M, up 2,100.48% year-over-year. In the year 2023, Santhera Pharmaceuticals Holding AG had annual revenue of 103.41M with 1,283.84% growth.
Revenue (ttm)
113.59M
Revenue Growth
+2,100.48%
P/S Ratio
0.78
Revenue / Employee
2.52M
Employees
45
Market Cap
100.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 103.41M | 95.94M | 1,283.84% |
| Dec 31, 2022 | 7.47M | 9.07M | -568.53% |
| Dec 31, 2021 | -1.60M | -16.60M | -110.63% |
| Dec 31, 2020 | 15.01M | -60.37M | -80.09% |
| Dec 31, 2019 | 75.38M | 43.72M | 138.10% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 60.58B |
| Roche Holding AG | 60.58B |
| Novartis AG | 42.18B |
| Lonza Group AG | 6.70B |
| Galderma Group AG | 3.88B |
| Sonova Holding AG | 3.71B |
| Straumann Holding AG | 2.54B |
| Ypsomed Holding AG | 548.53M |
Santhera Pharmaceuticals Holding AG News
- 2 months ago - Santhera Pharmaceuticals reports 1H results - Seeking Alpha
- 2 months ago - Santhera Enters into an Exclusive Distribution Agreement with GENESIS Pharma for AGAMREE® (Vamorolone) in Central and Eastern Europe - GlobeNewsWire